CASTLE BIOSCIENCES INC Annual Deferred Income Tax Expense (Benefit) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Castle Biosciences Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
  • Castle Biosciences Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Castle Biosciences Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$223K, a 88.1% increase from 2022.
  • Castle Biosciences Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.88M.
  • Castle Biosciences Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$8.74M.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$223K +$1.65M +88.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$1.88M +$6.86M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$8.74M* -$8.74M Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.